Patents by Inventor Henry Windle

Henry Windle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for production of bacterioferritin
    Patent number: 7901907
    Abstract: A nucleic acid sequence encoding all or part of an 18-19 kDa Helicobater pylori protein is described to which immunoreactivity is detected in H. pylori negative individuals. A process for the production of a recombinant form of this protein and its use, particularly as a vaccine to provide immunological protection against H. pylori infection are also described.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: March 8, 2011
    Assignee: The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
    Inventors: William Byrne, Dermot P. Kelleher, Henry Windle, Ross McManus
  • Helicobacter pylori bacterioferritin
    Publication number: 20070110765
    Abstract: A nucleic acid sequence encoding all or part of an 18-19 kDa Helicobater pylori protein is described to which immunoreactivity is detected in H. pylori negative individuals. A process for the production of a recombinant form of this protein and its use, particularly as a vaccine to provide immunological protection against H. pylori infection are also described.
    Type: Application
    Filed: August 25, 2006
    Publication date: May 17, 2007
    Inventors: William Bryne, Dermot Kelleher, Henry Windle, Ross McManus
  • Helicobacter proteins and vaccines
    Publication number: 20070104731
    Abstract: A vaccine includes at least one Helicobacter, especially Helicobacter pylori protein to which immunoreactivity is detected in H. pylori negative individuals. The Helicobacter proteins are preferably less than 30 kDa and the vaccine especially includes 24 to 25 kDa and/or 18 to 19 kDa proteins. The vaccine may include interleukin 12 as an adjuvant.
    Type: Application
    Filed: September 8, 2006
    Publication date: May 10, 2007
    Inventors: Dermot Kelleher, Henry Windle, William Byrne, Ross McManus
  • Clostridium difficile vaccine
    Publication number: 20070065466
    Abstract: A vaccine for the treatment or prophylaxis of C. difficile associated disease comprises a C. difficile gene or a C. difficile peptide/polypeptide or a derivative or fragment or mutant or variant thereof which is immunogenic in humans. The gene encodes a C. difficile surface layer protein, SlpA or variant or homologue thereof. The peptide/polypeptide is a C. difficile surface layer protein, SlpA or variant or homologue thereof. The vaccine may comprise a chimeric nucleic acid sequence.
    Type: Application
    Filed: April 24, 2006
    Publication date: March 22, 2007
    Inventors: Henry Windle, Rachael Doyle, Dermot Kelleher, James Walsh, Deirdre Ni Eidhin
  • HELICOBACTER PROTEINS AND VACCINES
    Publication number: 20010010821
    Abstract: A vaccine includes at least one Helicobacter, especially Helicobacter pylori protein to which immunoreactivity is detected in H. pylori negative individuals. The Helicobacter proteins are preferably less than 30 kDa and the vaccine especially includes 24 to 25 kDa and/or 18 to 19 kDa proteins. The vaccine may include interleukin 12 as an adjuvant.
    Type: Application
    Filed: December 31, 1996
    Publication date: August 2, 2001
    Inventors: DERMOT KELLEHER, HENRY WINDLE, WILLIAM BYRNE, ROSS MCMANUS